Smartleaf Asset Management »

Protalix Biotherapeutics shares owned by Smartleaf Asset Management

Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by Smartleaf Asset Management from 13F filings

Historical chart of Smartleaf Asset Management investment in Protalix Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protalix Biotherapeutics held by Smartleaf Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protalix Biotherapeutics by Smartleaf Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $45k 26k 1.74

More positions owned by Smartleaf Asset Management

Dimensional Etf Trust Us Equity Market (DFUS)
Ishares Tr Core S&p500 Etf (IVV)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Microsoft Corporation (MSFT)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Tr Core Us Aggbd Et (AGG)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Dimensional Etf Trust Internatnal Val (DFIV)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Ishares Tr Core Msci Eafe (IEFA)
Amazon (AMZN)
Vanguard World Mega Cap Val Etf (MGV)

View all positions for Smartleaf Asset Management

Top funds holding Protalix Biotherapeutics

BlackRock
Opaleye Management
Renaissance Technologies
Northern Trust
Geode Capital Management
State Street Corporation
Stratos Wealth Partners
Vanguard Group
Jane Street
Goldman Sachs Group
UBS Group
Connor, Clark & Lunn Investment Management
Main Street Financial Solutions
Bank of New York Mellon
Bridgeway Capital Management

View all funds holding Protalix Biotherapeutics